President and CEO Doug Love outlined a series of anticipated clinical and regulatory milestones during the 25th Annual ...
Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the contribution of the lectin pathway remains unclear. Lectin pathway-dependent ...
The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
ARCHER II Topline Pivotal Phase 3 Data in Geographic Atrophy (GA) Expected Q4 2026; Vonaprument has Potential to Be the First Vision-Preserving ...
MedPage Today on MSN
Cemdisiran siRNA therapy demonstrates efficacy in myasthenia gravis
Investigational treatment improves outcomes without complete complement blockade ...
A replay of the webcast will be archived on the Annexon website for 30 days following the presentation. Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted ...
Discover large garden ideas to give your outdoor space more beauty and functionality. Think: pathways, trellises, raised beds ...
D-Wave Quantum stock gains attention amid institutional activity and quantum computing developments. Explore key drivers ...
At UC, 70% of undergrads participate in research, creative projects or service learning. Three new programs bridge classroom ...
A detailed overview of NeuroSalt's five-ingredient plant-based nerve health supplement - covering botanical formula ...
Last October, commuters travelling along Craigflower Road might have noticed the sudden disappearance of a familiar ...
Detailed price information for Intl Business Machines (IBM-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results